Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients

After initially hypothesizing a positive relationship between use of renin-angiotensin-aldosterone system inhibitors and risk of coronavirus disease 2019 (COVID-19), more recent evidence suggests negative associations. We examined whether COVID-19 risk differs according to antihypertensive drug clas...

Descripción completa

Detalles Bibliográficos
Autores principales: Semenzato, Laura, Botton, Jérémie, Drouin, Jérôme, Baricault, Bérangère, Vabre, Clémentine, Cuenot, François, Penso, Laetitia, Herlemont, Philippe, Sbidian, Emilie, Weill, Alain, Dray-Spira, Rosemary, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884243/
https://www.ncbi.nlm.nih.gov/pubmed/33423528
http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884243/
https://www.ncbi.nlm.nih.gov/pubmed/33423528
http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16314

Ejemplares similares